Sangamo Therapeutics Reports Fourth Quarter And Full Year 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. LDOS
8. HUM
9. CSCO
10. KTOS

Go back to Sangamo Therapeutics Reports Fourth Quarter And Full Year 2017 Financial Results

Sangamo Therapeutics (SGMO) Tops Q4 EPS by 3c

February 22, 2018 7:22 AM EST

Sangamo Therapeutics (NASDAQ: SGMO) reported Q4 EPS of ($0.15), $0.03 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $13.1 million versus the consensus estimate of $11.43 million.

For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.

... More